GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 47.1

(-1.26%)

Total Assets Summary of GeneFerm Biotechnology Co., Ltd.

  • GeneFerm Biotechnology Co., Ltd.'s latest annual total assets in 2023 was 1.17 Billion TWD , down -1.2% from previous year.
  • GeneFerm Biotechnology Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 1.23 Billion TWD , up 2.73% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported annual total assets of 1.18 Billion TWD in 2022, down -9.66% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported annual total assets of 1.31 Billion TWD in 2021, up 34.02% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported quarterly total assets of 1.2 Billion TWD for 2024 Q1, up 2.59% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported quarterly total assets of 1.17 Billion TWD for 2023 Q4, down -4.43% from previous quarter.

Annual Total Assets Chart of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Historical Annual Total Assets of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 1.17 Billion TWD -1.2%
2022 1.18 Billion TWD -9.66%
2021 1.31 Billion TWD 34.02%
2020 982.57 Million TWD -1.79%
2019 1 Billion TWD 0.0%

Peer Total Assets Comparison of GeneFerm Biotechnology Co., Ltd.

Name Total Assets Total Assets Difference
Allied Biotech Corporation 2.07 Billion TWD 43.462%
Easywell Biomedicals, Inc. 1.21 Billion TWD 3.164%
TTY Biopharm Company Limited 9.87 Billion TWD 88.097%
Synmosa Biopharma Corporation 11.72 Billion TWD 89.979%
Orient EuroPharma Co., Ltd. 10.81 Billion TWD 89.129%
Center Laboratories, Inc. 27 Billion TWD 95.647%
Tien Liang BioTech Co., Ltd. 654.03 Million TWD -79.711%
Orient Pharma Co., Ltd. 2.56 Billion TWD 54.135%
InnoPharmax Inc. 524.19 Million TWD -124.224%
Johnson Chemical Pharmaceutical Works Co., Ltd. 1.99 Billion TWD 41.023%
Excelsior Biopharma Inc. 1.57 Billion TWD 25.483%
DV Biomed Co., Ltd. 1.81 Billion TWD 35.157%
Foresee Pharmaceuticals Co., Ltd. 1.86 Billion TWD 36.857%
Handa Pharmaceuticals, Inc. 3.03 Billion TWD 61.301%
UniPharma Co., Ltd. 350.07 Million TWD -235.75%
Anxo Pharmaceutical Co., Ltd. 2.21 Billion TWD 47.021%
Alar Pharmaceuticals Inc. 973.2 Million TWD -20.774%
Winston Medical Supply Co., Ltd. 801.77 Million TWD -46.596%
Mercury Biopharmaceutical Corporation 438.07 Million TWD -168.305%
Bioray Biotech Co., Ltd 542.64 Million TWD -116.6%
TSH Biopharm Corporation Limited 1.39 Billion TWD 16.036%